Radnostix Q2 Loss Widens to $882K; Revenue Down 27% on Product Recalls
INIS sits 43% above its 52-week low of $0.045.
Summary
Radnostix's Q2 2026 net loss widened to $882K as revenue dropped 27% due to product recalls. The company also terminated a $12.5M asset sale and added $500K in related-party debt.
Key Events · Earnings and Guidance · INIS
-
Q2 Net Loss Widens
Net loss of $881,997 for Q2 2026, up from $160,785 in Q2 2025. Six-month net loss of $2,230,083 versus $273,479 a year ago.
-
Revenue Down 27%
Q2 revenue of $2,671,785, down 27% from $3,655,320. The decline was driven by two voluntary product recalls that caused an estimated $850,000 in lost sales.
-
DUF6 Asset Sale Terminated
The company mutually terminated the DUF6 asset sale with American Fuel Resources, which would have provided $12.5 million in proceeds. The company is now seeking to monetize the NRC license.
-
New Related-Party Debt
Borrowed $500,000 from Kershner Grosso & Co., managed by the Chairman, with a 5% interest rate and conversion rights at $0.07 per share.
Analysis · INIS · Industrial Applications And Services
Radnostix reported a net loss of $881,997 for Q2 2026, a sharp deterioration from the $160,785 loss a year ago. Revenue fell 27% to $2.67 million, driven by two voluntary product recalls in January and February 2026 that cost an estimated $850,000 in lost sales. The company also terminated its DUF6 asset sale, which would have brought in $12.5 million, and took on $500,000 in new debt from a related party. These results confirm the operational and financial strain from the recalls and the failed asset sale, and the company's cash position has declined to $1.2 million.
At the time of this filing, INIS was trading at $0.06 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $34.2M. The 52-week trading range was $0.05 to $0.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.